- Home
- SNTI vs ZAPP Comparison
SNTI vs ZAPP Comparison
Compare SNTI & ZAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- ZAPP
- Stock Information
- Founded
- SNTI 2016
- ZAPP 2017
- Country
- SNTI United States
- ZAPP Thailand
- Employees
- SNTI 48
- ZAPP N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- ZAPP Motor Vehicles
- Sector
- SNTI Health Care
- ZAPP Consumer Discretionary
- Exchange
- SNTI Nasdaq
- ZAPP Nasdaq
- Market Cap
- SNTI 18.2M
- ZAPP 6.2M
- IPO Year
- SNTI N/A
- ZAPP N/A
- Fundamental
- Price
- SNTI $3.97
- ZAPP $1.30
- Analyst Decision
- SNTI Strong Buy
- ZAPP
- Analyst Count
- SNTI 1
- ZAPP 0
- Target Price
- SNTI $12.00
- ZAPP N/A
- AVG Volume (30 Days)
- SNTI 7.2M
- ZAPP 158.7K
- Earning Date
- SNTI 11-14-2024
- ZAPP 12-31-2024
- Dividend Yield
- SNTI N/A
- ZAPP N/A
- EPS Growth
- SNTI N/A
- ZAPP N/A
- EPS
- SNTI N/A
- ZAPP N/A
- Revenue
- SNTI N/A
- ZAPP N/A
- Revenue This Year
- SNTI $254.47
- ZAPP N/A
- Revenue Next Year
- SNTI $169.66
- ZAPP $53,347.33
- P/E Ratio
- SNTI N/A
- ZAPP N/A
- Revenue Growth
- SNTI N/A
- ZAPP N/A
- 52 Week Low
- SNTI $1.52
- ZAPP $0.70
- 52 Week High
- SNTI $16.94
- ZAPP $19.10
- Technical
- Relative Strength Index (RSI)
- SNTI 47.37
- ZAPP 28.94
- Support Level
- SNTI $3.60
- ZAPP $1.32
- Resistance Level
- SNTI $5.96
- ZAPP $1.87
- Average True Range (ATR)
- SNTI 1.02
- ZAPP 0.17
- MACD
- SNTI -0.29
- ZAPP -0.00
- Stochastic Oscillator
- SNTI 5.74
- ZAPP 6.15
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About ZAPP Zapp Electric Vehicles Group Limited
Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories.